U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C12H20N6O
Molecular Weight 264.3268
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NB-001

SMILES

NC1=C2N=CN(CCNCCCCCO)C2=NC=N1

InChI

InChIKey=CVPTTZZCRDVGSU-UHFFFAOYSA-N
InChI=1S/C12H20N6O/c13-11-10-12(16-8-15-11)18(9-17-10)6-5-14-4-2-1-3-7-19/h8-9,14,19H,1-7H2,(H2,13,15,16)

HIDE SMILES / InChI

Molecular Formula C12H20N6O
Molecular Weight 264.3268
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including: https://idsa.confex.com/idsa/2008/webprogram/Paper26299.html

NB-001, an oil-in-water emulsion containing high energy nanometer-sized droplets stabilized by surfactants is designed for topical treatment of herpes labialis infections. NB-001 diffuses through the stratum corneum via the follicular route to accumulate in the epidermal and dermal tissues, without disrupting the normal epithelial matrix. The concentrations achieved in the epidermis and dermis are well above the concentrations required for antiviral activity.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Doses

Doses

DosePopulationAdverse events​
0.5 % 5 times / day multiple, topical
Highest studied dose
Dose: 0.5 %, 5 times / day
Route: topical
Route: multiple
Dose: 0.5 %, 5 times / day
Sources:
unhealthy, ADULT
Health Status: unhealthy
Condition: herpes simplex
Age Group: ADULT
Sex: M+F
Food Status: UNKNOWN
Sources:
Overview

Overview

CYP3A4CYP2C9CYP2D6hERG

OverviewOther

Other InhibitorOther SubstrateOther Inducer

Drug as victim

Drug as victim

TargetModalityActivityMetaboliteClinical evidence
no
PubMed

PubMed

TitleDatePubMed
Treatment with a novel topical nanoemulsion (NB-001) speeds time to healing of recurrent cold sores.
2012 Aug
Patents

Patents

Sample Use Guides

Subjects applied 200 µL of NB-001 (0.1%, 0.3%, 0.5%) 5 times daily for a maximum of 4 days.
Route of Administration: Topical
Strains of HSV-1and HSV-2 (3 x 105 - 7.5 x 106 pfu/ml) were exposed to different concentrations of NB-001 for 15 minutes at room temperature and residual live virus was measured in a standard plaque-forming assay. The IC95 values of NB-001 against either HSV-1 or -2 virus ranged from 3 - 14 μg/ml.
Substance Class Chemical
Created
by admin
on Sat Dec 16 08:18:01 GMT 2023
Edited
by admin
on Sat Dec 16 08:18:01 GMT 2023
Record UNII
J89QT81NBQ
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NB-001
Common Name English
NB001
Code English
1-PENTANOL, 5-((2-(6-AMINO-9H-PURIN-9-YL)ETHYL)AMINO)-
Systematic Name English
HTS-09836
Code English
Code System Code Type Description
DRUG BANK
DB12716
Created by admin on Sat Dec 16 08:18:01 GMT 2023 , Edited by admin on Sat Dec 16 08:18:01 GMT 2023
PRIMARY
FDA UNII
J89QT81NBQ
Created by admin on Sat Dec 16 08:18:01 GMT 2023 , Edited by admin on Sat Dec 16 08:18:01 GMT 2023
PRIMARY
CAS
686301-48-4
Created by admin on Sat Dec 16 08:18:01 GMT 2023 , Edited by admin on Sat Dec 16 08:18:01 GMT 2023
PRIMARY
EPA CompTox
DTXSID30384648
Created by admin on Sat Dec 16 08:18:01 GMT 2023 , Edited by admin on Sat Dec 16 08:18:01 GMT 2023
PRIMARY
PUBCHEM
2815031
Created by admin on Sat Dec 16 08:18:01 GMT 2023 , Edited by admin on Sat Dec 16 08:18:01 GMT 2023
PRIMARY